Overview
Mangala Hegde practices practicing medicine in Guwahati, India.
Their clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Lung Metastases.
They are actively involved in clinical research, co-authoring 51 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mangala V. Hegde
Is Mangala V. Hegde a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Mangala V. Hegde is classified as an Experienced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mangala V. Hegde participate in research or clinical trials?
Yes. Mangala V. Hegde has published 51 articles and abstracts on conditions like Breast Cancer. You can view a list of Mangala V. Hegde's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerHegde isExperienced. Learn about Breast Cancer.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Lung MetastasesHegde isExperienced. Learn about Lung Metastases.
- Triple-Negative Breast CancerHegde isExperienced. Learn about Triple-Negative Breast Cancer.